New blood test could spot ovarian cancer earlier – study launches
NCT ID NCT07491081
First seen Mar 29, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This study is testing a new blood test that looks for tiny particles (called extracellular vesicles) which may help detect ovarian cancer earlier. Researchers will collect blood samples from 1,500 postmenopausal women aged 50–74 in Queensland, Australia. The goal is to see if the test is practical and reliable in real-world settings, which could lead to better screening for ovarian cancer in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mater Misericordiae Ltd
RECRUITINGBrisbane, Queensland, Australia
Contact
Contact Email: •••••@•••••
-
The University of Queensland
RECRUITINGBrisbane, Queensland, Australia
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.